Ignite Creation Date:
2024-05-06 @ 7:19 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05972629
Status:
RECRUITING
Last Update Posted:
2024-02-12
First Post:
2023-06-23
Brief Title:
A Phase 1Phase 2 Open-label Study to Evaluate the Safety Tolerability and Efficacy of a Single Intravenous Administration of SAR444836 in Adult Participants With Phenylketonuria
Sponsor:
Sanofi
Organization:
Sanofi
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2027-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-23
First Submit QC Date:
July 31 2023
Study First Post Date:
2023-08-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-15
Last Update Post Date:
2024-02-12
Last Update Post Date Type:
ACTUAL